Clinuvel Pharmaceuticals Ltd
ASX:CUV
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Price:
15.45 AUD
1.25%
Market Closed
Updated:
May 17, 2024
Clinuvel Pharmaceuticals Ltd
Operating Expenses
|
Clinuvel Pharmaceuticals Ltd
Operating Expenses Peer Comparison
Comparables:
IMM
MSB
CSL
TLX
PYC
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Operating Expenses
-AU$44.5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-18%
|
|
|
Immutep Ltd
ASX:IMM
|
Operating Expenses
-AU$47.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-10%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Operating Expenses
-$41.1m
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Operating Expenses
-$3.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Operating Expenses
-AU$296.8m
|
CAGR 3-Years
-97%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Operating Expenses
-AU$42.8m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-23%
|
See Also
What is Clinuvel Pharmaceuticals Ltd's Operating Expenses?
Operating Expenses
-44.5m
AUD
-44.5m
AUD
Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's Operating Expenses amounts to -44.5m AUD.
What is Clinuvel Pharmaceuticals Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-18%
-18%
Over the last year, the Operating Expenses growth was -46%. The average annual Operating Expenses growth rates for Clinuvel Pharmaceuticals Ltd have been -36% over the past three years , -28% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
